E-LIB Suche - Ergebnisse für: Procaccianti, Claudio

1

Differential Performance and Lung Deposition of Levofloxaci..:

Schwarz, Carsten ; Procaccianti, Claudio ; Costa, Laura...
International Journal of Molecular Sciences. 23 (2022) 17 - p. 9597 , 2022

Link: https://doi.org/10.3390/..

2

Prolonged-Release Once-Daily Formulation of Tacrolimus Vers..:

Budde, Klemens ; Rostaing, Lionel ; Maggiore, Umberto...
Transplant International. 35 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

3

Management of ChronicPseudomonas AeruginosaInfection with I..:

Elborn, J Stuart ; Flume, Patrick A ; Van Devanter, Donald R.
Future Microbiology. 16 (2021) 14 - p. 1087-1104 , 2021

Link: https://doi.org/10.2217/..

4

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs..:

Schwarz, Carsten ; Procaccianti, Claudio ; Mignot, Benjamin...
Pharmaceutics. 13 (2021) 12 - p. 2051 , 2021

Link: https://doi.org/10.3390/..

5

The Cell Transformation Assay: Toward a Statistical Classif..:

Procaccianti, Claudio ; Stefanini, Federico M. ; Urani, Chiara
Alternatives to Laboratory Animals. 39 (2011) 1 - p. 23-36 , 2011

Link: https://doi.org/10.1177/..

6

Differential Performance and Lung Deposition of Levofloxaci..:

Schwarz, Carsten ; Procaccianti, Claudio ; Costa, Laura...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455972/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Prolonged-Release Once-Daily Formulation of Tacrolimus Vers..:

Budde, Klemens ; Rostaing, Lionel ; Maggiore, Umberto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397503/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Management of chronic Pseudomonas aeruginosa infection with..:

Elborn, J Stuart ; Flume, Patrick A ; Van Devanter, Donald R.
Elborn , J S , Flume , P A , Van Devanter , D R & Procaccianti , C 2021 , ' Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis ' , Future microbiology , vol. 16 , no. 14 , pp. 1087–1104 . https://doi.org/10.2217/fmb-2021-0150. , 2021

Link: https://pure.qub.ac.uk/e..

9

Effect of Concentration/Dose Ratio in De Novo Kidney Transp..:

Suwelack, Barbara ; Bunnapradist, Suphamai ; Meier-Kriesche, Ulf...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412936/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Whole Genome Analysis and MicroRNAs Regulation in HepG2 Cel..:

FABBRI Marco ; URANI Chiara ; SACCO Maria-Grazia..
JRC68093. , 2012

Link: https://publications.jrc..

11

Quantitative evaluation of in vitro transformation by analy..:

PROCACCIANTI, CLAUDIO
alleditors:STEFANINI, FEDERICO. , 2012

Link: http://hdl.handle.net/10..

12

Differential Performance and Lung Deposition of Levofloxaci..:

Carsten Schwarz ; Claudio Procaccianti ; Laura Costa...
Molecular Toxicology. , 2022

Link: https://doi.org/10.3390/..

13

Differential Performance and Lung Deposition of Levofloxaci..:

Carsten Schwarz ; Claudio Procaccianti ; Laura Costa...
https://www.mdpi.com/1422-0067/23/17/9597. , 2022

Link: https://doi.org/10.3390/..

14

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs..:

Carsten Schwarz ; Claudio Procaccianti ; Benjamin Mignot...
Drug Delivery and Controlled Release. , 2021

Link: https://doi.org/10.3390/..

15

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs..:

Carsten Schwarz ; Claudio Procaccianti ; Benjamin Mignot...
https://www.mdpi.com/1999-4923/13/12/2051. , 2021

Link: https://doi.org/10.3390/..